Meet the Precision
AQ team at
AMCP 2026
Nashville, TN | April 13-16, 2026
Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.
Our proprietary Access Made Possible technology integrates payer, provider, and patient insights to deliver scalable, actionable strategies that widen access to innovation. At Precision AQ, we believe access is earned with evidence, empathy, and precision.
Our market access specialists help teams understand payer decision-making and anticipate barriers before they emerge. We combine real-time payer intelligence with strategic analysis to support positioning, pull-through, and launch readiness. The result is a clear, evidence-backed path to broader patient access.
Complete the form to book a meeting, and we’ll reach out to confirm the details.
Jenny Chen, MSc | Senior Director, Precision AQ Emma Hawe, MSc | Senior Vice President, Managing Director, Precision AQ...
Eve Jamali| SVP, Managing Director, US Access Strategy & Analytics Andrew Cournoyer | SVP, Head of Access Experience...
Madeline Waldron, PharmD, BCOP | Vice President, Clinical Oncology Solutions